We developed and invested in new lab facilities at the University of Warwick, to give UK drug discovery companies access to solid-state NMR and advanced mass spectrometry and liquid handling technology.
Located in the Warwick School of Life Sciences, our facilities are targeted at developing new complex biological assays and advanced biochemical analysis, utilising the first ‘quad’ solid state NMR probe in the UK. These facilities will enable the industrial and academic communities to innovate together for better medicines.
The initial focus will be on tackling the increasing threat of antimicrobial resistance (AMR).
